ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
The Asia-Pacific joint pain injections market is forecasted to grow with a CAGR of 8.84% during the projected years of 2022 to 2030. The market growth is fueled by the rising focus of market players in the region, the augmenting incidence of orthopedic diseases, increased healthcare expenditure, the surging population, and the availability of advanced technology.
ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
Asia-Pacific Market by Joint Type (Knee, Shoulder and Elbow, Hip, Foot and Ankle, Other Joint Types) Market by Injection Type (Hyaluronic Acid, Corticosteroid, Other Drugs) Market by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) by Geography
The Asia-Pacific joint pain injections market is forecasted to grow with a CAGR of 8.84% during the projected years of 2022 to 2030. The market growth is fueled by the rising focus of market players in the region, the augmenting incidence of orthopedic diseases, increased healthcare expenditure, the surging population, and the availability of advanced technology.
To learn more about this report, request a free sample copy
The Asia-Pacific joint pain injections market growth analysis constitutes the evaluation of South Korea, Singapore, Taiwan, Australia & New Zealand, India, Japan, China, Indonesia, and Rest of Asia-Pacific. China is the largest producer as well as exporter of pharmaceuticals. The nation exports massive quantities of pharmaceuticals to the Asia-Pacific pharmaceutical and chemical divisions. Furthermore, the increasing demand for market players across the region has significantly leveraged the market’s growth in China. The country’s government also invests in developing special industrial zones, facilitating infrastructure production and advancements at affordable prices.
Conversely, India’s healthcare industry has continued to witness rapid transformation over the years. Key aspects such as the geriatric population and the growing prevalence of orthopedic conditions, in addition to the increasing income as well as affordability, result in higher demand and utility of healthcare services in the country. Moreover, India also harbors lucrative growth opportunities on account of the surging medical tourism that demands technologically advanced medical proficiencies. Hence, these drivers are set to reinforce the Asia-Pacific joint pain injections market growth.
Seikagaku Corporation is a pharmaceutical company engaged in the commercialization and development of glycoconjugates-based drugs as well as therapeutic platforms. It is operational under two business segments, namely, LAL business and pharmaceutical business. The company has four manufacturing facilities, with two situated in Japan and two in the United States and Canada. Seikagaku Corporation has a significant presence in Japan, China, and the United States. The company is headquartered in Tokyo, Japan.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- PARENT MARKET ANALYSIS: ORTHOPEDIC PROCEDURES MARKET
- KEY DRIVERS
- BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
- GROWING NUMBER OF SPORT INJURIES
- PREVALENCE OF MUSCULOSKELETAL DISORDERS
- KEY RESTRAINTS
- HIGH COSTS OF JOINT REPAIR THERAPIES
- SIDE EFFECTS ASSOCIATED WITH JOINT REPAIR INJECTIONS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ALLERGAN PLC (ACQUIRED BY ABBVIE)
- ANIKA THERAPEUTICS INC
- BIOVENTUS INC
- CHUGAI PHARMACEUTICAL
- FERRING PHARMACEUTICALS
- FIDIA PHARMA USA INC
- FLEXION THERAPEUTICS INC
- ORTHOGENRX INC
- PFIZER INC
- SANOFI
- SEIKAGAKU CORPORATION
- SMITH & NEPHEW PLC
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- ZIMMER BIOMET HOLDINGS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS
TABLE 2: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021
FIGURE 6: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2030 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021
FIGURE 12: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 16: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 20: CHINA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: JAPAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: INDIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: AUSTRALIA & NEW ZEALAND JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: SOUTH KOREA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: INDONESIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: TAIWAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: SINGAPORE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.